Hosokawa, Kohei http://orcid.org/0000-0002-3423-1523
Yamazaki, Hirohito
Tanabe, Mikoto
Imi, Tatsuya
Sugimori, Naomi
Nakao, Shinji http://orcid.org/0000-0002-9674-624X
Article History
Received: 8 June 2020
Revised: 16 June 2020
Accepted: 23 June 2020
First Online: 3 July 2020
Compliance with ethical standards
:
: HY received research funding from Otsuka Pharmaceutical and Alexion Pharma, and honoraria from Novartis Pharma, Kyowa Kirin, Sanofi, Nippon Shinyaku, Chugai Pharmaceutical and Fuji Pharma. SN received honoraria fees and lecture fees from Novartis Pharma K.K. and Kyowa-Kirin K.K. KH, MT, TI, and NS declare that they have no conflicts of interest to report.